Cleared Traditional

TOPEZ TOTAL ANKLE REPLACEMENT (K051023) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2005
Decision
207d
Days
Class 2
Risk

K051023 is an FDA 510(k) clearance for the TOPEZ TOTAL ANKLE REPLACEMENT. Classified as Prosthesis, Ankle, Semi-constrained, Cemented, Metal/polymer (product code HSN), Class II - Special Controls.

Submitted by Topez Orthopedics, Inc. (Boulder, US). The FDA issued a Cleared decision on November 15, 2005 after a review of 207 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3110 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Topez Orthopedics, Inc. devices

Submission Details

510(k) Number K051023 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 2005
Decision Date November 15, 2005
Days to Decision 207 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
85d slower than avg
Panel avg: 122d · This submission: 207d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HSN Prosthesis, Ankle, Semi-constrained, Cemented, Metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3110
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - HSN Prosthesis, Ankle, Semi-constrained, Cemented, Metal/polymer

All 56
Devices cleared under the same product code (HSN) and FDA review panel - the closest regulatory comparables to K051023.
INBONE TOTAL ANKLE SYSTEM MODEL 200347902
K103374 · Wrightmedicaltechnologyinc · Dec 2010
INBONE II TOTAL ANKLE REPLACEMENT
K100886 · Wrightmedicaltechnologyinc · Aug 2010
AGILITY LP TOTAL ANKLE PROSTHESIS
K053569 · DePuy Orthopaedics, Inc. · Mar 2006
AGILITY ANKLE REVISION PROSTHESIS
K020541 · Depuy, Inc. · May 2002
ALVINE TOTAL ANKLE
K920802 · Depuy, Inc. · Dec 1992
BRIGHAM TOTAL ANKLE PROSTHESIS
K803167 · Howmedica Corp. · Feb 1981